Smpd1 Gene Acid Sphingomyelinase is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
SMPD1 (Sphingomyelin Phosphodiesterase 1) encodes acid sphingomyelinase (ASM), a lysosomal enzyme that hydrolyzes sphingomyelin to ceramide and phosphorylcholine. Mutations in SMPD1 cause Niemann-Pick disease types A and B, lysosomal storage disorders characterized by sphingomyelin accumulation in macrophages throughout the reticuloendothelial system. [1]
| infobox | [2]
|---| [3]
| SMPD1 Gene | [4]
| Full Name | Sphingomyelin Phosphodiesterase 1, Acid Lysosomal |
| Symbol | SMPD1 |
| Chromosomal Location | 11p15.4 |
| NCBI Gene ID | 6609 |
| OMIM | 257200 |
| Ensembl ID | ENSG00000166311 |
| UniProt | P17405 |
| Associated Diseases | Niemann-Pick Disease Type A/B, Acid Sphingomyelinase Deficiency (ASMD) |
The SMPD1 gene encodes acid sphingomyelinase (ASM), a lysosomal hydrolase enzyme that catalyzes the hydrolysis of sphingomyelin to ceramide and phosphorylcholine. This enzyme plays a critical role in lipid metabolism and cellular signaling within the lysosomal compartment.
ASM is synthesized as a preproenzyme in the endoplasmic reticulum, processed through the Golgi apparatus, and targeted to lysosomes via mannose-6-phosphate receptor-mediated trafficking. The mature enzyme is a 75 kDa glycoprotein consisting of an N-terminal catalytic domain and a C-terminal domain.
Niemann-Pick disease type A (NPD-A) and type B (NPD-B) are caused by autosomal recessive mutations in the SMPD1 gene, resulting in deficient or absent acid sphingomyelinase activity.
While NPD-A/B are classically lysosomal storage disorders, the accumulated sphingomyelin and secondary ceramide elevation contribute to neurodegeneration through:
Research suggests altered sphingolipid metabolism may play roles in:
SMPD1 is expressed ubiquitously with highest expression in:
In the brain, ASM is expressed in neurons, astrocytes, microglia, and oligodendrocytes, with particular importance in white matter tracts.
The study of Smpd1 Gene Acid Sphingomyelinase has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.